期刊文献+

富马酸替诺福韦二吡呋酯杂质的合成 被引量:1

Synthesis of The Impurities of Tenofovir Disoproxil Fumarate
下载PDF
导出
摘要 为控制富马酸替诺福韦二吡呋酯的产品质量,以腺嘌呤为起始物料,合成了5种杂质:(R)-1-(6-氨基-9H-嘌呤-9-基)丙基-2-醇,(R)-【{[1-(6-氨基-9H-嘌呤-9-基)丙基-2-基]氧基}甲基】磷酸,【【{[(R)-1-(6-氨基-9H-嘌呤-9-基)丙基-2-基]氧}甲基】(羟基)磷酸】氧】甲基异丙基碳酸酯,【【【{[(R)-1-(6-氨基-9H-嘌呤-9-基)丙基-2-基]氧}甲基】(异并氧基)磷】氧】甲基异并氧基碳酸酯和(R)-异丙基【9-【2-【【双{[(异丙氧羰基)氧]甲氧}磷】甲氧基】丙】-9H-嘌呤-6-基】氨基碳酸酯,其结构经UV-Vis,1H NMR,13C NMR,MS(ESI)和元素分析确证。 To control the quality of the tenofovir disoproxil fumarate,five impurities including(R)-1-(6-amino-9H-purin-9-yl)propan-2-ol,(R)-{{[1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl}phosphonic acid,{{{{[(R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl}(hydroxy)phosphoryl}oxy}methyl isopropyl carbonate,{{{{[(R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl}(isopropoxy)phosphoryl}oxy}methyl isopropyl carbonate and(R)-isopropyl{9-{2-{{bis{[(isopropoxycarbonyl)oxy]methoxy}phosphoryl}methoxy}propyl}-9H-purin-6-yl}carbamate were synthesized from the starting material adenine.The structures were confirmed by UV-Vis,^1H NMR,^13C NMR,MS(ESI)and elemental analysis.
作者 黄小光 朱少璇 陈金瑞 HUANG Xiao-guang;ZHU Shao-xuan;CHEN Jin-rui(Guangzhou Baiyunshan Pharmaceutical General Factory,Guangzhou Baiyunshan Pharmaceutical Co.,Ltd.,Guangzhou 510515,China)
出处 《合成化学》 CAS CSCD 北大核心 2018年第12期934-938,共5页 Chinese Journal of Synthetic Chemistry
基金 广州市产学研合作专项(2014Y2-00001)
关键词 富马酸替诺福韦二吡呋酯 腺嘌呤 杂质 合成 质量控制 tenofovir disoproxil fumarate adenine impurity synthesis quality control
  • 相关文献

参考文献6

二级参考文献159

  • 1聂青和.拉米夫定应用中的问题及处理[J].中国实用内科杂志,2004,24(8):457-459. 被引量:16
  • 2崔岚,安富荣,王晓珉.核苷酸逆转录酶抑制剂替诺福韦DF[J].中国新药杂志,2004,13(11):1054-1058. 被引量:30
  • 3聂青和.慢性乙型肝炎抗病毒治疗进展回顾[J].实用肝脏病杂志,2005,8(3):148-150. 被引量:16
  • 4聂青和,张久聪.拉米夫定治疗慢性乙型肝炎耐药性的基础与临床研究[J].世界华人消化杂志,2006,14(19):1853-1858. 被引量:8
  • 5聂青和,李梦东.加强病毒性肝炎的基础与临床研究[J].胃肠病学和肝病学杂志,2007,16(1):95-99. 被引量:12
  • 6[1]Robbins BL,Srinivas RV,Kim C,et al.Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA),Bis(isopropyloxymethylcarbonyl)PMPA[J].Antimicrob Agents Chemother,1998,42(3):612-617.
  • 7[2]Arimilli MN,Kim CU,Dougherty J,et al.Synthesis,in vitro biological evaluation and oral bioavailability of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) prodrugs[J].Antivir Chem Chemother,1997,8(6):557-564.
  • 8[3]Hossain MM,Coull JJ,Drusano GL,et al.Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir,didanosine,and tenofovir[J].Antiviral Res,2002,55(1):41-52.
  • 9[4]Cihlar T,Ho ES,Lin DC,et al.Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs[J].Nucleosides Nucleic Acids,2001,20(4-7):641-648.
  • 10[5]Zidek Z,Frankova D,Holy A.Activation by 9-(R)-[2-(phosphonomethoxy)propyl]adenine of chemokine (RANTES,macrophage inflammatory protein 1α) and cytokine (tumor necrosis factor α,interleukin-10[IL-10],IL-1β) production[J].Antimicrob Agents Chemother,2001,45(12):3381-3386.

共引文献54

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部